| 12319671 |
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
Hua Zhou, John J. Acton, III, Michael J. Ardolino, Yi-Heng Chen, Peter H. Fuller +15 more |
2025-06-03 |
|
| 11174248 |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
John J. Acton, III, David A. Candito, J. Michael Ellis, Peter H. Fuller, Hakan Gunaydin +6 more |
2021-11-16 |
$200,946,000 |
| 11072602 |
Antidiabetic heterocyclic compounds |
Michael Miller, Harry R. Chobanian, Shuwen He, Jinsong Hao |
2021-07-27 |
$304,446,000 |
| 10968232 |
Antidiabetic spirochroman compounds |
Michael Miller, Harry R. Chobanian, Shuwen He, Jinsong Hao, Yan Guo +1 more |
2021-04-06 |
$229,405,000 |
| 10662171 |
Antidiabetic bicyclic compounds |
Harry R. Chobanian, Duane DeMong, Yan Guo, Christopher W. Plummer |
2020-05-26 |
$186,154,000 |
| 10059667 |
Antidiabetic compounds |
Harry R. Chobanian, Duane DeMong, Yan Guo, Zhiyong Hu, Michael Miller +3 more |
2018-08-28 |
$100,134,000 |
| 10000484 |
Inhibitors of the renal outer medullary potassim channel |
Harry R. Chobanian, Yan Guo, Fa-Xiang Ding, Shuzhi Dong, Shawn P. Walsh +2 more |
2018-06-19 |
$67,511,000 |
| 9957219 |
Antidiabetic bicyclic compounds |
Thomas Bara, Harry R. Chobanian, Yan Guo, Hubert Josien, Michael Miller +3 more |
2018-05-01 |
$129,774,000 |
| 9840512 |
Antidiabetic bicyclic compounds |
Linda Brockunier, Helen Chen, Harry R. Chobanian, Matthew J. Clements, Alejandro Crespo +7 more |
2017-12-12 |
$85,898,000 |
| 9834563 |
Antidiabetic substituted heteroaryl compounds |
William K. Hagmann, Bing Li, Jason W. Szewczyk, Bowei Wang, Dann Parker +15 more |
2017-12-05 |
$49,639,000 |
| 9751881 |
Inhibitors of the renal outer medullary potassium channel |
Haifeng Tang, Jinlong Jiang, Alexander Pasternak, Shuzhi Dong, Ronald D. Ferguson +7 more |
2017-09-05 |
$112,151,000 |
| 9604998 |
Inhibitors of the renal outer medullary potassium channel |
Alexander Pasternak, Reynalda K. DeJesus, Fa-Xiang Ding, Shuzhi Dong, Jessica Frie +5 more |
2017-03-28 |
$91,458,000 |
| 9573961 |
Inhibitors of the renal outer medullary potassium channel |
Alexander Pasternak, Reynalda K. DeJesus, Jessica Frie, Haifeng Tang, Shawn P. Walsh |
2017-02-21 |
$159,401,000 |
| 9527830 |
Inhibitors of the renal outer medullary potassium channel |
Shawn P. Walsh, Alexander Pasternak, Brian Cato, Paul E. Finke, Jessica Frie +5 more |
2016-12-27 |
$78,520,000 |
| 9469608 |
Thrombin inhibitors |
Harry R. Chobanian, Tesfaye Biftu, Zhicai Wu |
2016-10-18 |
$133,900,000 |
| 9340530 |
Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists |
Mihir Mandal, Timothy A. Blizzard, Helen Chen, Harry R. Chobanian, Yan Guo +4 more |
2016-05-17 |
$80,713,000 |
| 9206199 |
Inhibitors of the renal outer medullary potassium channel |
Alexander Pasternak, Aurash Shahripour, Haifeng Tang, Shawn P. Walsh |
2015-12-08 |
$101,156,000 |
| 9139585 |
Inhibitors of the Renal Outer Medullary Potassium channel |
Shawn P. Walsh, Alexander Pasternak, Reynalda K. DeJesus, Haifeng Tang, Aurash Shahripour +8 more |
2015-09-22 |
$66,869,000 |
| 9073882 |
Inhibitors of the renal outer medullary potassium channel |
Haifeng Tang, Alexander Pasternak, Lihu Yang, Shawn P. Walsh, Aurash Shahripour +1 more |
2015-07-07 |
$67,990,000 |
| 9062070 |
Inhibitors of the renal outer medullary potassium channel |
Alexander Pasternak, Timothy A. Blizzard, Harry R. Chobanian, Reynalda De Jesus, Fa-Xiang Ding +6 more |
2015-06-23 |
$67,157,000 |
| 9056859 |
Inhibitors of the renal outer medullary potassium channel |
Alexander Pasternak, Reynalda K. DeJesus, Yuping Zhu, Lihu Yang, Shawn P. Walsh +4 more |
2015-06-16 |
$310,064,000 |
| 8999991 |
Inhibitors of the renal outer medullary potassium channel |
Haifeng Tang, Harry R. Chobanian |
2015-04-07 |
$36,039,000 |
| 8999990 |
Inhibitors of the renal outer medullary potassium channel |
Haifeng Tang, Nardos Teumelsan, Alexander Pasternak, Reynalda K. DeJesus |
2015-04-07 |
$36,039,000 |
| 8236819 |
Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
Bharat Lagu, Rimma Lebedev |
2012-08-07 |
$54,274,000 |
| 7772236 |
Substituted pyrazoles |
Mary Pat Beavers, J. Guy Breitenbucher, Hui Cai, James P. Edwards, Cheryl A. Grice +5 more |
2010-08-10 |
|
